First update of the living European guideline (<scp>EuroGuiDerm</scp>) on atopic eczema
Andreas Wollenberg(University Hospital Augsburg), Carsten Flohr(King's College London), N. Aszodi(LMU Klinikum), C Roxburgh, Johannes Ring(Technical University of Munich), Thomas Werfel(Medizinische Hochschule Hannover), Giampiero Girolomoni(University of Verona), Krisztián Gáspár(University of Debrecen), Mariateresa Rossi(Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia), B.W.M. Arents(European Federation of Allergy and Airways Diseases Patients Associations), Nicole Fosse(University Hospital of Basel), Thomas Bieber(CK-CARE), Stamatios Gregoriou(Andreas Sygros Hospital), Mette Deleuran(Aarhus University Hospital), Uwe Gieler(Universitätsklinikum Gießen und Marburg), Alexander Nast(Humboldt-Universität zu Berlin), Antonio Torrelo(Hospital Infantil Universitario Niño Jesús), S. Barbarot(Hotel Dieu Hospital), Louise A. A. Gerbens(Amsterdam UMC Location University of Amsterdam), E. Serra‐Baldrich(Universitat Autònoma de Barcelona), Maria Kinberger(Humboldt-Universität zu Berlin), Charlotte G. Mørtz(University of Southern Denmark), Uffe Nygaard(Aarhus University Hospital), Dagmar Simon(University of Bern), Stéphanie Christen‐Zaech(Centre Hospitalier Universitaire Vaudois), Helen A. Brough(Guy's and St Thomas' NHS Foundation Trust), Jacek C. Szepietowski(Wroclaw Medical University), Zsuzsanna Szalai(Heim Pál Országos Gyermekgyógyászati Intézet), Martin Dittmann(Humboldt-Universität zu Berlin), Eva Maria Rehbinder(Oslo University Hospital)
Cited by 26
Related Papers
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
Atopic dermatitis
|Nature Reviews Disease Primers|2018|1.5k
The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria
|Allergy|2018|1.5k
Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
|New England Journal of Medicine|2014|1.4k